Forbes J M & CO LLP Biogen Inc. Transaction History

Forbes J M & CO LLP

$1 Billion
Q3 2024

A detailed history of Forbes J M & CO LLP transactions in Biogen Inc. stock. As of the latest transaction made, Forbes J M & CO LLP holds 1,869 shares of BIIB stock, worth $324,813. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,869

Previous 1,869 -0.0%

Holding current value

$324,813

Previous $433,000 16.4%

% of portfolio

0.04%

Previous 0.05%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 11, 2024	SELL	$212.02 - $267.71 $8,268 - $10,440	-39 Reduced 2.04%	1,869 $403,000
Q3 2023 Nov 02, 2023	SELL	$253.3 - $285.89 $43,061 - $48,601	-170 Reduced 8.18%	1,908 $490,000
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $5,387 - $6,139	-21 Reduced 1.0%	2,078 $578,000
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $10,707 - $14,765	55 Added 2.69%	2,099 $560,000
Q1 2022 May 09, 2022	SELL	$193.77 - $244.14 $7,750 - $9,765	-40 Reduced 1.92%	2,044 $430,000
Q3 2021 Nov 05, 2021	SELL	$282.99 - $369.05 $9,055 - $11,809	-32 Reduced 1.51%	2,084 $590,000
Q2 2021 Aug 03, 2021	SELL	$259.0 - $414.71 $1,295 - $2,073	-5 Reduced 0.24%	2,116 $733,000
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $2,429 - $2,846	-10 Reduced 0.47%	2,121 $593,000
Q4 2020 Feb 11, 2021	SELL	$236.26 - $355.63 $4,725 - $7,112	-20 Reduced 0.93%	2,131 $522,000
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $230,673 - $292,612	-858 Reduced 28.51%	2,151 $681,000
Q3 2018 Nov 02, 2018	SELL	$293.51 - $383.83 $2,935 - $3,838	-10 Reduced 0.33%	3,009 $1.06 Million
Q1 2018 Apr 18, 2018	SELL	$260.13 - $367.91 $28,614 - $40,470	-110 Reduced 3.52%	3,019 $827,000
Q4 2017 Feb 09, 2018	BUY	$307.64 - $344.58 $2,461 - $2,756	8 Added 0.26%	3,129 $997,000
Q2 2017 Aug 10, 2017	BUY	N/A	3,121	3,121 $846,000

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Forbes J M & CO LLP, based on Form 13F filings with the SEC.

News

Stay updated on Forbes J M & CO LLP with notifications on news.

Account